Robeco Institutional Asset Management B.V. grew its holdings in Cognex Co. (NASDAQ:CGNX) by 20.7% in the third quarter, Holdings Channel reports. The institutional investor owned 8,325 shares of the scientific and technical instruments company’s stock after acquiring an additional 1,425 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Cognex were worth $465,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Capital Analysts LLC lifted its holdings in Cognex by 1,180.6% during the 2nd quarter. Capital Analysts LLC now owns 2,305 shares of the scientific and technical instruments company’s stock worth $103,000 after purchasing an additional 2,125 shares during the last quarter. CAPROCK Group Inc. acquired a new stake in Cognex during the 3rd quarter worth approximately $221,000. Chatham Capital Group Inc. acquired a new stake in Cognex during the 3rd quarter worth approximately $232,000. Advisor Partners LLC lifted its holdings in Cognex by 26.6% during the 2nd quarter. Advisor Partners LLC now owns 5,418 shares of the scientific and technical instruments company’s stock worth $242,000 after purchasing an additional 1,140 shares during the last quarter. Finally, Oakbrook Investments LLC acquired a new stake in Cognex during the 3rd quarter worth approximately $318,000. 90.47% of the stock is owned by institutional investors.
In related news, Director Jerry A. Schneider sold 5,000 shares of the business’s stock in a transaction on Tuesday, September 11th. The stock was sold at an average price of $54.29, for a total transaction of $271,450.00. Following the sale, the director now owns 7,000 shares in the company, valued at approximately $380,030. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Anthony Sun sold 10,000 shares of the business’s stock in a transaction on Thursday, September 13th. The stock was sold at an average price of $56.04, for a total value of $560,400.00. Following the sale, the director now owns 264,262 shares in the company, valued at approximately $14,809,242.48. The disclosure for this sale can be found here. Insiders own 5.40% of the company’s stock.
Shares of NASDAQ CGNX opened at $40.85 on Monday. The firm has a market capitalization of $7.03 billion, a price-to-earnings ratio of 28.17, a P/E/G ratio of 2.27 and a beta of 1.90. Cognex Co. has a fifty-two week low of $36.16 and a fifty-two week high of $72.71.
Cognex (NASDAQ:CGNX) last announced its quarterly earnings data on Monday, October 29th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.37 by $0.08. The firm had revenue of $232.22 million during the quarter, compared to analysts’ expectations of $227.15 million. Cognex had a return on equity of 20.88% and a net margin of 18.52%. The company’s quarterly revenue was down 12.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.14 EPS. Equities research analysts anticipate that Cognex Co. will post 1.2 earnings per share for the current fiscal year.
Cognex announced that its board has approved a share repurchase plan on Monday, October 29th that authorizes the company to repurchase $200.00 million in outstanding shares. This repurchase authorization authorizes the scientific and technical instruments company to buy up to 2.8% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s management believes its stock is undervalued.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 30th. Investors of record on Friday, November 16th will be given a dividend of $0.05 per share. The ex-dividend date is Thursday, November 15th. This represents a $0.20 dividend on an annualized basis and a yield of 0.49%. This is a positive change from Cognex’s previous quarterly dividend of $0.05. Cognex’s payout ratio is currently 13.79%.
Cognex Company Profile
Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes worldwide. The company offers machine vision products, which are used to automate the manufacturing and tracking of discrete items, such as mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.
Featured Article: Can individual investors take part in an IPO?
Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Co. (NASDAQ:CGNX).
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.